Financials climbed across the board in anticipation that a new Trump administration will take a friendlier approach to Wall ...

Investing.com -- Shares of Barry Callebaut (SIX: BARN) rose following its results, which showed a stronger-than-expected ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 Healthcare Conference on Tuesday, ...

In a report released today, Matthew Sheerin from Stifel Nicolaus maintained a Hold rating on Sensata (ST – Research Report), with a price ...

Stifel analyst Chris O’Cull downgraded Portillo’s (PTLO) to Hold from Buy with a $13 price target The company reported disappointing same-restaurant-sales and traffic performance, with EBITDA above ...

Shares of Bowlero Corp ( NYSE: BOWL) are building on Monday's after-hours gains and are up 16% from the previous close as the ...

Election Day is just about here, marking an end to the unpredictable ride that has been the 2024 presidential race following ...

A few days ago, it said it had sold off a small portion of its wealth management business to Stifel Financial Corp. for up to ...

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...

JPMorgan analysts noted the 8% weight loss at the highest dose is more than any of the competitor oral drugs that are in development. Analysts led by Hardik Parikh called it a "great outcome" and ...

Across the recent three months, 33 analysts have shared their insights on Okta OKTA, expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent assessments, the table ...